Our findings suggest that the obtained hit compounds named Lig_1, Lig_6, and Lig_14 have the potential to inhibit SHP2 and can be useful for developing novel allosteric SHP2 inhibitors in cancer (Figure 1). This evidence concerns the gene PTPN11 and cancer.